Could this non-invasive device relieve treatment-resistant pain?
150 years ago, red light was found to relieve musculoskeletal pain and impairments.
In 1903, Dr. Finsen was awarded a Nobel Prize for Medicine.
He found blue wavelengths to stimulate nerves.
The uses for wavelengths in-between have still not been widely studied.
As nerdy engineers, we don’t have a clue why. Neither do our advisory anesthesiologists or neurologists.
We asked a basic question.
Could 1, 2, or a sequence of wavelengths relieve treatment-resistant pain?
Is it neuroplasticity? Quantum entanglement? Your best guess?
PhotoMed’s did what Silicon Valley engineers do. They developed tools that could objectively prompt and record outcomes to the therapy. They thought that maybe something special was going on.
Data from the Instant Verification System™ suggest that the body returns-to-its-normal functions. Some call this the switch from “chronic” to homeostasis. Could this event go unnoticed for most people upon healing from an injury?
What will patients see?
For example, watch the variation of green (560nm) through yellow (600nm) wavelengths of the light being applied to a leg wound.
Warning: link presents close-up graphic images of wounds
Have you ever seen fresh exudates enter a wound?
What could you observe?
You can now prompt and monitor for objectively measurable responses in real time. You may already do that for adjusting therapies to match your patient’s needs.
PhotoMed’s Instant Verification System™ records responses to the therapy at the physiological level:
The outcomes appear to be the return-to-normal functions. The normal functions self-maintain after therapy ends. Some call that homeostasis.
Could it be the interruption of functions, for years, that makes the responses and outcomes so unexpected?
PhotoMed’s team started with novel questions:
Does the body need one, two, or a sequence of wavelengths to resume its normal functions?
Could varying the wavelength during therapy increase the likelihood of success for your patients?
Could missing wavelengths result in nothing happening?
These are no longer speculative questions.
The Vari-Chrome® Pro lets you deliver light energy with no missing wavelengths. It’s about improving efficiency by finding effective wavelengths for each individual disorder.
Why are all wavelengths needed?
Consider basic neuroscience and the conversations and outcomes possible with just two nerves. Each of 282+ wavelengths could be “A” or “B” in the figure. The number of
Here are only a few.
Does it work?
To find out which treatment-resistant disorders might respond to the therapy, PhotoMed’s team invented the Instant Verification System™.
More than 500 people volunteered in studies to learn if the therapy might relieve their pain or improve their functions. The studies at 6 sites included people with disorders which were not expected to improve.
Many arrived with multiple sites of pain or impairments. Their disorders could resolve at different times and with procedures using different wavelengths.
Link to a list of disorders that responded to the therapy.
Unfortunately, in the studies, the therapy failed in 2 out of 3 cases, like previous attempts but without side effects. That was with “real-world” people unexpected to improve.
Patients in 1 of 3 cases reported significant improvement.
That includes people with disorders that have never been tested before (likely because no one expected improvements). For example, swallowing and gait disorders improved in a man with Huntington’s disease.
When will it work?
As software engineers, we do not get why you must wait so long for outcomes.
Success was judged by when a physiological response marks improving impaired functions.
In about 2 minutes, you can typically observe a physiological response, or not, to each procedure. That’s 1000x faster than conventional testing of medications, but with the same logic.
That efficiency translates to needing only 2 visits with no response to detect probable failure for that disorder.
Vari-Chrome® Pro operators will be brought up to speed on how to use PhotoMed’s Triple 2 Algorithm. The algorithm also lets you know when it might be time to quit.
We’re still trying to reduce the failure rate below 2 out of 3 cases of treatment-resistant pain or impairments.